Engineering of Affibody Molecules
Cold Spring Harbor Protocols · 2024-11 · 2024 (11) · pdb.top107760
DOI: 10.1101/pdb.top107760 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cold Spring Harbor Protocols, online erschienen am 25.07.2023. Verfasst von Stefan Ståhl und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Protein Science, KTH Royal Institute of Technology, 106 91 Stockholm, Sweden ssta@kth.se. Hauptthemen laut MEDLINE: Protein Engineering, Recombinant Fusion Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Affibody molecules are small, robust, and versatile affinity proteins currently being explored for therapeutic, diagnostic, and biotechnological applications. Surface-exposed residues on the affibody scaffold are randomized to create large affibody libraries from which novel binding specificities to virtually any protein target can be generated using combinatorial protein engineering. Affibody molecules have the potential to complement—or even surpass—current antibody-based technologies, exhibiting multiple desirable properties, such as high stability, affinity, and specificity, efficient tissue penetration, and straightforward modular extension of functional domains. It has been shown in both preclinical and clinical studies that affibody molecules are safe, efficacious, and valuable alternatives to antibodies for specific targeting in the context of in vivo diagnostics and therapy. Here, we provide a general background of affibody molecules, give examples of reported applications, and briefly summarize the methodology for affibody generation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Protein Science, KTH Royal Institute of Technology, 106 91 Stockholm, Sweden ssta@kth.se.
- Department of Protein Science, KTH Royal Institute of Technology, 106 91 Stockholm, Sweden.
Zitieren
APA
Ståhl, S., Lindberg, H., Hjelm, L. C., Löfblom, J., & Dahlsson Leitao, C. (2024). Engineering of Affibody Molecules. Cold Spring Harbor Protocols, 2024(11), pdb.top107760. https://doi.org/10.1101/pdb.top107760
Vancouver
Ståhl S, Lindberg H, Hjelm LC, Löfblom J, Dahlsson Leitao C. Engineering of Affibody Molecules. Cold Spring Harbor Protocols. 2024;2024(11):pdb.top107760. doi:10.1101/pdb.top107760
BibTeX
@article{Sthl2024,
author = {Ståhl, Stefan and Lindberg, Hanna and Hjelm, Linnea Charlotta and Löfblom, John and Dahlsson Leitao, Charles},
title = {Engineering of Affibody Molecules},
journal = {Cold Spring Harbor Protocols},
year = {2024},
volume = {2024},
number = {11},
pages = {pdb.top107760},
doi = {10.1101/pdb.top107760}
}
EUVIMED